Describe the clinical characteristics, treatment strategies, and outcome data of children with papilledema associated with Lyme disease at a large tertiary care pediatric hospital.
Methods
Retrospective cohort study of children 1-18 years old who received care at our institution between 1995 and 2019 with concurrent diagnoses of papilledema and Lyme disease. Data were abstracted from records and prospective family surveys.
Results
Among 44 children included (median age 9.7 years), 66% (29/44) had additional cranial neuropathies, and 78% (32/41) had cerebrospinal fluid pleocytosis. All children were treated with antibiotics (39% oral, 55% intravenous, 7% both); 61% (27/44) were also treated with oral acetazolamide. Symptoms fully resolved in 86% (30/35) of children with follow-up data. Proportion recovered did not significantly differ by antibiotic administration route or presence/absence of cerebrospinal fluid pleocytosis.
Conclusions
Papilledema in Lyme disease may occur with or without cerebrospinal fluid pleocytosis. Most children recover without residual deficits following treatment, although exceptions exist.
SchwartzAMHinckleyAFMeadPSHookSAKugelerKJ. Surveillance for Lyme disease - United States, 2008-2015. MMWR Surveill Summ. 2017;66(22):1. doi:https://doi.org/10.15585/mmwr.ss6622a1
2.
NelsonCASahaSKugelerKJ, et al.Incidence of clinician-diagnosed Lyme disease, United States, 2005-2010. Emerg Infect Dis. 2015;21(9):1625‐1631. doi:https://doi.org/10.3201/eid2109.150417
BorchersATKeenCLHuntleyACGershwinME. Lyme disease: a rigorous review of diagnostic criteria and treatment. J Autoimmun. 2015;57:82‐115. doi:https://doi.org/10.1016/j.jaut.2014.09.004
HuppertzHIMünchmeierDLiebW. Ocular manifestations in children and adolescents with Lyme arthritis. Br J Ophthalmol.1999;83(10):1149‐1152. doi:https://doi.org/10.1136/bjo.83.10.1149
7.
LantosPMRumbaughJBockenstedtLK, et al.Clinical practice guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease. Neurology. 2021;96(6):262‐273. doi:https://doi.org/10.1212/WNL.0000000000011151
8.
RaucherHSKaufmanDMGoldfarbJJacobsonRIRosemanBWolffRR. Pseudotumor cerebri and Lyme disease: a new association. J Pediatr. 1985;107(6):931‐933. doi:https://doi.org/10.1016/S0022-3476(85)80193-1
EzequielMTeixeiraATBritoMJLuísC. Pseudotumor cerebri as the presentation of Lyme disease in a non-endemic area. BMJ Case Rep. March 30, 2018;2018:bcr-2017-222976. doi:https://doi.org/10.1136/bcr-2017-222976
KauffmannDJHWormserGP. Ocular Lyme disease: case report and review of the literature. Br J Ophthalmol.1990;74(6):325‐327. doi:https://doi.org/10.1136/bjo.74.6.325
BelmanALIyerMCoylePKDattwylerR. Neurologic manifestations in children with north American Lyme disease. Neurology. 1993;43(12):2609‐2614.
15.
EppesSCNelsonDKLewisLLKleinJD. Characterization of Lyme meningitis and comparison with viral meningitis in children. Pediatrics. 1999;103(5 I):957‐960. doi:https://doi.org/10.1542/peds.103.5.957
16.
RamgopalSObeidRZuccoliGCleves-BayonCNowalkA. Lyme disease-related intracranial hypertension in children: clinical and imaging findings. J Neurol. 2016;263(3):500‐507. doi:https://doi.org/10.1007/s00415-015-8007-x
ŠkiljićDGustavssonMDotevallLNorrsellKGrönlundMA. Ophthalmological findings in neuroborreliosis - a prospective study performed in western Sweden. Acta Ophthalmol. 2019;97(1):44‐52. doi:https://doi.org/10.1111/aos.13884
19.
Recommendations for Test Performance and Interpretation From the Second National Conference on Serologic Diagnosis of Lyme Disease. J Am Med Assoc. 1995;274(12):937. doi:https://doi.org/10.1001/jama.1995.03530120023018
AveryRAShahSSLichtDJ, et al.Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med.2010;363(9):891‐893. doi:https://doi.org/10.1056/NEJMc1004957
22.
TeamRC. R: A Language and Environment for Statistical Computing. R Foundation; 2021.
MalleryRMRehmaniOFWooJH, et al.Utility of magnetic resonance imaging features for improving the diagnosis of idiopathic intracranial hypertension without papilledema. J Neuroophthalmol.2019;39(3):299‐307. doi:https://doi.org/10.1097/WNO.0000000000000767
25.
AveryRAFrankGGluttingJJEppesSC. Prediction of lyme meningitis in children from a Lyme disease-endemic region: a logistic-regression model using history, physical, and laboratory findings. Pediatrics. 2006;117(1):e1-e7. doi:https://doi.org/10.1542/peds.2005-0955
26.
BelmanALReynoldsLPrestonTPostelsDGrimsonRCoylePK. Cerebrospinal fluid findings in children with Lyme disease-associated facial nerve palsy. Arch Pediatr Adolesc Med. 1997;151(12):1224‐1228. doi:https://doi.org/10.1001/archpedi.1997.02170490050009
27.
HalperinJJShapiroEDLogigianE, et al.Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69(1):91‐102. doi:https://doi.org/10.1212/01.wnl.0000265517.66976.28
28.
PickeringLK, Pediatrics. AA of. Red Book: 2006 Report of the Committee on Infectious Diseases, 27th Edition. 27th ed. American Academy of Pediatrics; 2006. doi:https://doi.org/10.3201/eid1212.061045
29.
CohnKAThompsonADShahSS, et al.Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Pediatrics. 2012;129(1):e46‐e53. doi:https://doi.org/10.1542/peds.2011-1215
30.
NigrovicLEThompsonADFineAMKimiaA. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a lyme disease-endemic area. Pediatrics. 2008;122(5):e1080‐e1085. doi:https://doi.org/10.1542/peds.2008-1273
31.
KanLSoodSKMaytalJPseudotumorMJ. Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol. 1998;18(5):439‐441.
32.
SteenhoffAPSmithMJShahSSCoffinSE. Neuroborreliosis with progression from pseudotumor cerebri to aseptic meningitis. Pediatr Infect Dis J.2006;25(1):91‐92. doi:https://doi.org/10.1097/01.INF.0000195643.74134.8B
33.
AbererEBrunnerCSuchanekG, et al.Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol. 1989;26(6):732‐737. doi:https://doi.org/10.1002/ANA.410260608
34.
Carlos Garcia-MoncoJColemanJLBenachJL. Antibodies to myelin basic protein in Lyme disease. J Infect Dis. 1988;158(3):667‐668. doi:https://doi.org/10.1093/INFDIS/158.3.667
35.
SmithSVFriedmanDI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57(8):1303‐1310. doi:https://doi.org/10.1111/head.13144
36.
RubinRCHendersonESOmmayaAKWalkerMDRallDP. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg.1966;25(4):430‐436. doi:https://doi.org/10.3171/jns.1966.25.4.0430
